Reference range(s)
The reference ranges listed below are valid on this date of May 29, 2026.
| Component | Age | Male Norm | Male Critical Low | Male Critical High | Female Norm | Female Critical High | Female Critical Low | Units | Add'l info |
|---|---|---|---|---|---|---|---|---|---|
| Tissue IFA Observation(s) | ALL | See report. | |||||||
| ANNA1 (Hu) Ab, IFA | ALL | See report. | |||||||
| ANNA2 (Ri) Ab, IFA | ALL | See report. | |||||||
| ANNA3 Ab, IFA | ALL | See report. | |||||||
| PCA1 (Yo) Ab, IFA | ALL | See report. | |||||||
| PCA2 Ab, IFA | ALL | See report. | |||||||
| PCA-Tr (DNER) Ab, IFA | ALL | See report. | |||||||
| AGNA/SOX1 Ab, IFA | ALL | See report. | |||||||
| Amphiphysin Ab, IFA | ALL | See report. | |||||||
| CRMP5/CV2 Ab, IFA | ALL | See report. | |||||||
| GAD65 Ab, IFA | ALL | See report. | |||||||
| Ma2/Ta Ab, IFA | ALL | See report. | |||||||
| Myelin Ab, IFA | ALL | See report. | |||||||
| Aquaporin 4 (NMO) Ab, IFA | ALL | See report. | |||||||
| Aquaporin-4 Ab (IgG), CBA | ALL | See report. | |||||||
| NMDAR1 Ab, CBA | ALL | See report. | |||||||
| AMPAR1 Ab, CBA | ALL | See report. | |||||||
| AMPAR2 Ab, CBA | ALL | See report. | |||||||
| GABABR Ab, CBA | ALL | See report. | |||||||
| LGI1 Ab, CBA | ALL | See report. | |||||||
| CASPR2 Ab, CBA | ALL | See report. | |||||||
| DPPX Receptor Ab, CBA IFA | ALL | See report. | |||||||
| AChR Ganglionic (Alpha3) Ab | ALL | See report. | |||||||
| VGCC Type P/Q Ab | ALL | See report. | |||||||
| VGCC Type N Ab | ALL | See report. | |||||||
| VGKC Ab | ALL | See report. |